| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |